Substituting lower-wage staff for registered nurses tied to worse outcomes
Jun 25, 2024
Harms include avoidable patient deaths, readmissions, longer lengths of stay, excess Medicare costs and forgone cost savings.
Medicare to cover Wegovy when patients also have heart disease
Mar 22, 2024
Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, US officials announced Thursday.
Racial and ethnic disparities seen in use of hospice
Dec 18, 2023
Older age was associated with lower odds of short length of stay in those dually eligible for Medicare and Medicaid.
Million hearts model cuts five-year heart attack, stroke risk in at-risk patients
Oct 18, 2023
Improved outcomes were seen, with no significant changes in Medicare spending.
Heart, diabetes, cancer drugs on list for Medicare price negotiations, White House says
Aug 29, 2023
Enrollees in the Medicare prescription drug program paid a total of $3.4 billion in out-of-pocket costs in 2022 for the 10 initial drugs chosen for price negotiations.
2012 to 2015 saw rise in US insulin prices
Jun 16, 2023
However, the introduction of new insulin products after 2015 was followed by substantial discounting practices that lowered net prices.
Medicare spending would increase $2.0 to $5.1 billion with lecanemab
May 18, 2023
$2.0 to $5.1 billion would include lecanemab and ancillary costs; estimated annual per-patient coinsurance could reach $6,636
Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
Medicare monthly premiums to drop for seniors
Sep 28, 2022
The fee cuts come at the same time as seniors receive a Social Security cost-of-living increase for 2023 of up to 9 or 10%.
Medicare could have saved $3.6 billion on generic drugs in 2020
Jun 20, 2022
The authors say that Medicare could have saved up to $3.6 billion by purchasing generics at Mark Cuban Cost Plus Drug Co. prices.